The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Adds BHP Billiton To Conviction Buy List

Thu, 15th Jan 2015 09:49

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
GOLDMAN SACHS RAISES BHP BILLITON TO 'CONVICTION BUY LIST' ('NEUTRAL') - PRICE TARGET 1575 (1870) PENCE
----------
NOMURA CUTS BG GROUP PRICE TARGET TO 900 (1000) PENCE - 'REDUCE'
----------
JEFFERIES CUTS BG GROUP PRICE TARGET TO 1215 (1250) PENCE - 'BUY'
----------
NOMURA CUTS BP PRICE TARGET TO 380 (430) PENCE - 'NEUTRAL'
----------
JEFFERIES CUTS BP PRICE TARGET TO 470 (490) PENCE - 'BUY'
----------
JEFFERIES CUTS SHELL A PRICE TARGET TO 2450 (2540) PENCE - 'BUY'
----------
NOMURA CUTS SHELL B PRICE TARGET TO 2350 (2600) PENCE - 'BUY'
----------
S&P CAPITAL IQ CUTS BHP BILLITON TO 'HOLD' ('BUY') - PRICE TARGET 1300 (1825) PENCE
----------
UBS CUTS BHP BILLITON PRICE TARGET TO 1870 (2000) PENCE - 'BUY'
----------
BARCLAYS CUTS BHP BILLITON PRICE TARGET TO 1500 (2100) PENCE - 'OVERWEIGHT'
----------
S&P CAPITAL IQ RAISES BURBERRY PRICE TARGET TO 1520 (1420) PENCE - 'SELL'
----------
TRADERS: NUMIS CUTS ANTOFAGASTA TO 'REDUCE' ('HOLD')
----------
S&P CAPITAL IQ CUTS ANTOFAGASTA TO 'SELL' ('HOLD') - TARGET 625 (760) PENCE
----------
BARCLAYS CUTS ANTOFAGASTA PRICE TARGET TO 700 (745) PENCE - 'EQUAL WEIGHT'
----------
S&P CAPITAL IQ CUTS RIO TINTO PRICE TARGET TO 2800 (3300) PENCE - 'HOLD'
----------
UBS CUTS RIO TINTO PRICE TARGET TO 3300 (3500) PENCE - 'BUY'
----------
BERNSTEIN RAISES RBS PRICE TARGET TO 470 (450) PENCE - 'OUTPERFORM'
----------
BARCLAYS CUTS ANGLO AMERICAN PRICE TARGET TO 1080 (1550) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES FRESNILLO PRICE TARGET TO 835 (800) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES RANDGOLD RESOURCES TARGET TO 5600 (4900) PENCE - 'OVERWEIGHT'
----------
TRADERS: NUMIS CUTS RANDGOLD RESOURCES TO 'HOLD' ('BUY')
----------
BARCLAYS RAISES COMPASS GROUP PRICE TARGET TO 1250 (1180) PENCE - 'OVERWEIGHT'
----------
CS CUTS COMPASS GROUP TO 'NEUTRAL' ('OUTPERFORM') - TARGET 190 PENCE
----------
BARCLAYS RAISES INTERCONTINENTAL HOTELS TARGET TO 2650 (2360) PENCE; 'EQUAL WEIGHT.'
----------
BARCLAYS RAISES WHITBREAD PRICE TARGET TO 5400 (4900) PENCE - 'OVERWEIGHT'
----------
Investec Raises BAT Price Target To 3,600P From 3,400P, Keeps At Hold
----------
EXANE BNP CUTS SKY PLC TO 'NEUTRAL' ('OUTPERFORM') - PRICE TARGET 1000 (985) PENCE
----------
EXANE BNP RAISES GKN PRICE TARGET TO 380 (340) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS SMITHS GROUP PRICE TARGET TO 1050 (1150) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS WEIR GROUP PRICE TARGET TO 1500 (1835) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 4800 (4350) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS GLAXOSMITHKLINE PRICE TARGET TO 1300 (1390) PENCE - 'HOLD'
----------
HSBC RAISES EASYJET PRICE TARGET TO 1500 (1450) PENCE - 'UNDERWEIGHT'
----------
HSBC CUTS ADMIRAL GROUP PRICE TARGET TO 1590 (1625) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS RSA INSURANCE PRICE TARGET TO 474 (480) PENCE - 'NEUTRAL'
----------
HSBC CUTS AVIVA PRICE TARGET TO 535 (590) PENCE - 'NEUTRAL'
----------
HSBC RAISES PRUDENTIAL PRICE TARGET TO 1800 (1725) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES DIRECT LINE PRICE TARGET TO 346 (335) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES FRIENDS LIFE PRICE TARGET TO 420 (415) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES LEGAL & GENERAL PRICE TARGET TO 296 (285) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS STANDARD LIFE PRICE TARGET TO 425 (430) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
JPMORGAN RAISES REDEFINE INTERNATIONAL TARGET TO 53 (50) PENCE - 'UNDERWEIGHT'
----------
BERENBERG INITIATES BODYCOTE WITH 'HOLD' - TARGET 684 PENCE
----------
SOCGEN RAISES PROVIDENT FINANCIAL PRICE TARGET TO 2540 (2270) PENCE - 'HOLD'
----------
TRADERS: NUMIS CUTS KAZ MINERALS TO 'REDUCE' ('HOLD')
----------
BARCLAYS CUTS KAZ MINERALS PRICE TARGET TO 150 (255) PENCE - 'EQUAL WEIGHT'
----------
CREDIT SUISSE RAISES LADBROKES TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 115 PENCE
----------
BARCLAYS CUTS LADBROKES PRICE TARGET TO 104 (126) PENCE - 'EQUAL WEIGHT'
----------
CREDIT SUISSE CUTS DOMINO'S PIZZA TO 'NEUTRAL' ('OUTPERFORM') - TARGET 695 (650) PENCE
----------
TRADERS: CITIGROUP RAISES JUPITER FUND TO 'BUY' ('NEUTRAL')
----------
BARCLAYS CUTS LONMIN PRICE TARGET TO 155 (190) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS RAISES ACACIA MINING TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
BARCLAYS CUTS PETRA DIAMONDS PRICE TARGET TO 280 (290) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES POLYMETAL TO 'EQUAL WEIGHT' ('UNDERWEIGHT')
----------
BARCLAYS CUTS VEDANTA PRICE TARGET TO 400 (840) PENCE - 'UNDERWEIGHT'
----------
EXANE BNP RAISES TALK TALK TELECOM TARGET TO 220 (200) PENCE - 'UNDERPERFORM'
----------
BARCLAYS RAISES MERLIN ENTERTAINMENTS TARGET TO 450 (420) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS WILLIAM HILL PRICE TARGET TO 390 (400) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS MARSTONS TO 'UNDERWEIGHT' ('EQUAL WEIGHT') - TARGET 130 (150) PENCE
----------
EXANE BNP RAISES HALMA TO 'OUTPERFORM' ('NEUTRAL') - TARGET 780 (685) PENCE
----------
EXANE BNP RAISES ROTORK TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 2300 PENCE
----------
EXANE BNP CUTS SPECTRIS TO 'UNDERPERFORM' ('NEUTRAL') - TARGET 1825 (1740) PENCE
----------
EXANE BNP RAISES SPIRAX-SARCO TO 'NEUTRAL' ('UNDERPERFORM')
----------
EXANE BNP RAISES SPIRAX-SARCO TARGET TO 2935 (2450) PENCE
----------
EXANE BNP RAISES VESUVIUS TO 'OUTPERFORM' ('NEUTRAL') - TARGET 510 (440) PENCE
----------
BARCLAYS RAISES BETFAIR PRICE TARGET TO 1626 (1576) PENCE - 'OVERWEIGHT'
----------
SOCGEN RAISES BBA AVIATION PRICE TARGET TO 400 (360) PENCE - 'BUY'
----------
HSBC CUTS CATLIN GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 720 (620) PENCE
----------
HSBC CUTS PHOENIX GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 875 (870) PENCE
----------
HSBC RAISES AMLIN PRICE TARGET TO 433 (420) PENCE - 'UNDERWEIGHT'
----------
HSBC RAISES ESURE GROUP PRICE TARGET TO 330 (320) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES HISCOX PRICE TARGET TO 715 (690) PENCE - 'NEUTRAL'
----------
HSBC RAISES LANCASHIRE HLDGS PRICE TARGET TO 655 (650) PENCE - 'OVERWEIGHT'
----------
MAIN MARKET AND AIM
----------
UBS CUTS FENNER PRICE TARGET TO 210 (235) PENCE - 'NEUTRAL'
----------
UBS CUTS PREMIER OIL PRICE TARGET TO 200 (300) PENCE - 'BUY'
----------
TRADERS: NUMIS CUTS PETROPAVLOVSK TO 'SELL' ('REDUCE')
----------
BARCLAYS CUTS FERREXPO TO 'UNDERWEIGHT' ('EQUAL WEIGHT.') - TARGET 50 (140) PENCE
----------
BARCLAYS CUTS GEM DIAMONDS PRICE TARGET TO 245 (260) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES HOCHSCHILD MINING TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
PANMURE RAISES SQS SOFTWARE PRICE TARGET TO 590 (527) PENCE - 'HOLD'
----------
HSBC RAISES FLYBE GROUP PRICE TARGET TO 150 (140) PENCE - 'OVERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.